Odyssey Therapeutics: Funding, Investors & Team (Oct 2026)
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines.
Odyssey Therapeutics has raised $725M across 5 funding rounds on record, the most recent an undisclosed round of $25.0M announced in May 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Odyssey Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2026.
Odyssey Therapeutics Funding Rounds
Odyssey Therapeutics raised $218M in a Series A announced in Dec 2021.
10 months later, a Series B of $168M was announced in Oct 2022.
1.2 years later, a Series C of $101M was announced in Dec 2023.
1.8 years later, a Series D of $213M was announced in Sep 2025.
8 months later, an undisclosed round of $25.0M was announced in May 2026.
Odyssey Therapeutics Founders and Leadership Team
Contact details for the Odyssey Therapeutics team: 3 of 4 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Odyssey Therapeutics Funding Compared to Other Biotechnology Startups
Odyssey Therapeutics' latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Odyssey Therapeutics in Biotechnology and Cambridge
Companies Similar to Odyssey Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Odyssey Therapeutics Funding FAQs
What does Odyssey Therapeutics do?
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines.
How much funding has Odyssey Therapeutics raised?
Odyssey Therapeutics has raised $725M across 5 rounds on record. The most recent is an undisclosed round of $25.0M announced in May 2026.
When did Odyssey Therapeutics last raise funding?
Odyssey Therapeutics' most recent funding round on record is an undisclosed round of $25.0M, announced in May 2026.
Who founded Odyssey Therapeutics?
FundedIQ lists David Pompliano (Founder), Gary D (Founder) at Odyssey Therapeutics.
Who is the CEO of Odyssey Therapeutics?
Gary Glick is listed as CEO at Odyssey Therapeutics.
Where is Odyssey Therapeutics headquartered?
Odyssey Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Odyssey Therapeutics have?
Odyssey Therapeutics is in the 51-100 employee band.
How does Odyssey Therapeutics' funding compare to other Biotechnology startups?
Odyssey Therapeutics' latest round of $25.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Odyssey Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Odyssey Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.